Department and Clinic of Endocrinology, Diabetes, and Isotope Therapy, Wrocław Medical University, Poland.
Endokrynol Pol. 2019;70(4):350-356. doi: 10.5603/EP.a2019.0022.
Trabecular bone score (TBS) index has recently been obtained as a result of textural greyscale analysis of DXA images. Because it enables the assessment of bone microarchitectural texture, TBS may be useful in evaluating bone quality. This study explores the current knowledge of the use of TBS in patients with endocrine disorders with co-occurring bone structure changes. Currently, the clinical importance TBS was verified in terms of disorders of the growth hormone/insulin-like growth factor 1 (GH/IGF-I) axis, glucocorticoid excess, thyroid and parathyroid disease, as well as in diabetes mellitus type 1 and 2. It has been clarified that patients suffering from various endocrinopathies are a group in which TBS should be used routinely because it correlates with clinical factors and may improve patient management in various endocrine disorders.
目前，TBS 的临床重要性已在生长激素/胰岛素样生长因子 1（GH/IGF-1）轴紊乱、糖皮质激素过多、甲状腺和甲状旁腺疾病以及 1 型和 2 型糖尿病等疾病中得到验证。已经明确的是，患有各种内分泌疾病的患者是 TBS 应该常规使用的一个群体，因为它与临床因素相关，并可能改善各种内分泌疾病患者的管理。
